How to safely discontinue lamotrigine (anticonvulsant medication)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Safely Discontinuing Lamotrigine

Lamotrigine should be discontinued gradually over a period of at least 4 weeks, reducing the dose by 25-33% of the original dose every week to minimize withdrawal symptoms and seizure risk. 1

Rationale for Gradual Tapering

Lamotrigine requires careful discontinuation due to several important factors:

  • Abrupt discontinuation may increase the risk of seizures, even in patients taking lamotrigine for mood disorders rather than epilepsy 1
  • The brain needs time to readjust to the absence of lamotrigine's effects on voltage-sensitive sodium channels and neurotransmitter release 1
  • Withdrawal symptoms may occur with rapid discontinuation 2

Standard Tapering Schedule

For a typical patient on lamotrigine (example using 300mg daily dose):

  1. Week 1: Reduce to 200mg daily (approximately 33% reduction)
  2. Week 2: Reduce to 150mg daily (50% of original dose)
  3. Week 3: Reduce to 100mg daily
  4. Week 4: Reduce to 50mg daily
  5. Week 5: Discontinue completely

Special Considerations

Higher Risk Patients

For patients at higher risk of adverse effects from discontinuation, consider a more gradual taper:

  • 6-8 week taper with 25% reductions every 2 weeks
  • Weekly reductions of smaller increments (e.g., 50mg per week) 1

Drug Interactions

  • If the patient is also taking enzyme-inducing medications (like carbamazepine, phenytoin, or oxcarbazepine), be aware that discontinuing these medications while continuing lamotrigine can lead to increased lamotrigine levels and potential toxicity 3
  • Conversely, if discontinuing lamotrigine while continuing valproate, remember that valproate decreases lamotrigine clearance, so tapering may need to be more gradual 4

Monitoring During Tapering

During the tapering period, patients should be monitored for:

  • Emergence of seizures (if lamotrigine was prescribed for epilepsy)
  • Mood symptoms (if prescribed for bipolar disorder) 5
  • Withdrawal symptoms including anhedonia, tremor, tachycardia, and hyperhydrosis 2

Potential Complications to Watch For

  • Withdrawal syndrome: Characterized by psychomotor inhibition, anhedonia, tremor, tachycardia, and excessive sweating 2
  • Seizure recurrence: Particularly in patients with epilepsy
  • Mood destabilization: In patients with bipolar disorder 5
  • Rare but serious adverse effects: While uncommon, be vigilant for any signs of Stevens-Johnson syndrome, which can occur with lamotrigine use 6

Common Pitfalls to Avoid

  1. Tapering too quickly: This increases risk of withdrawal symptoms and seizure recurrence
  2. Failing to adjust for drug interactions: Particularly important when multiple antiepileptic drugs are involved
  3. Inadequate monitoring: Patients should be informed about potential withdrawal symptoms and instructed to report concerning symptoms immediately
  4. Discontinuing in high-risk settings: Avoid initiating discontinuation before major life events or periods of high stress

By following a structured tapering schedule and monitoring patients closely, lamotrigine can be safely discontinued while minimizing the risk of adverse effects or symptom recurrence.

References

Guideline

Antiepileptic Drug Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Is there a lamotrigine withdrawal syndrome?

Acta neurologica Scandinavica, 2002

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Lamotrigine: A Safe and Effective Mood Stabilizer for Bipolar Disorder in Reproductive-Age Adults.

Medical science monitor : international medical journal of experimental and clinical research, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.